The Hatter Cardiovascular Institute, Institute of Cardiovascular Science, University College London, London, United Kingdom.
Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, Singapore, Singapore.
Sci Rep. 2019 Jul 11;9(1):10072. doi: 10.1038/s41598-019-46486-0.
We aimed to identify independent predictors of cardiac mortality and hospitalization for heart failure (HHF) from a real-world, multi-ethnic Asian registry [the Singapore Myocardial Infarction Registry] of ST-segment elevation myocardial infarction (STEMI) patients treated by primary percutaneous coronary intervention. 11,546 eligible STEMI patients between 2008 and 2015 were identified. In-hospital, 30-day and 1-year cardiac mortality and 1-year HHF rates were 6.4%, 6.8%, 8.3% and 5.2%, respectively. From the derivation cohort (70% of patients), age, Killip class and cardiac arrest, creatinine, hemoglobin and troponin on admission and left ventricular ejection fraction (LVEF) during hospitalization were predictors of in-hospital, 30-day and 1-year cardiac mortality. Previous ischemic heart disease (IHD) was a predictor of in-hospital and 30-day cardiac mortality only, whereas diabetes was a predictor of 1-year cardiac mortality only. Age, previous IHD and diabetes, Killip class, creatinine, hemoglobin and troponin on admission, symptom-to-balloon-time and LVEF were predictors of 1-year HHF. The c-statistics were 0.921, 0.901, 0.881, 0.869, respectively. Applying these models to the validation cohort (30% of patients) showed good fit and discrimination (c-statistic 0.922, 0.913, 0.903 and 0.855 respectively; misclassification rate 14.0%, 14.7%, 16.2% and 24.0% respectively). These predictors could be incorporated into specific risk scores to stratify reperfused STEMI patients by their risk level for targeted intervention.
我们旨在从真实世界、多民族亚洲注册登记处[新加坡心肌梗死注册登记处]中确定接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死(STEMI)患者心脏死亡和心力衰竭(HHF)住院的独立预测因素。在 2008 年至 2015 年间,共确定了 11546 例符合条件的 STEMI 患者。住院期间、30 天和 1 年的心脏死亡率和 1 年 HHF 发生率分别为 6.4%、6.8%、8.3%和 5.2%。从推导队列(70%的患者)中,入院时的年龄、Killip 分级和心搏骤停、肌酐、血红蛋白和肌钙蛋白以及住院期间的左心室射血分数(LVEF)是住院期间、30 天和 1 年心脏死亡率的预测因素。既往缺血性心脏病(IHD)仅预测住院期间和 30 天的心脏死亡率,而糖尿病仅预测 1 年的心脏死亡率。年龄、既往 IHD 和糖尿病、Killip 分级、肌酐、血红蛋白和肌钙蛋白入院时、症状至球囊时间和 LVEF 是 1 年 HHF 的预测因素。C 统计量分别为 0.921、0.901、0.881 和 0.869。将这些模型应用于验证队列(30%的患者)表明拟合和区分度良好(C 统计量分别为 0.922、0.913、0.903 和 0.855;错误分类率分别为 14.0%、14.7%、16.2%和 24.0%)。这些预测因素可以纳入特定的风险评分,根据风险水平对再灌注的 STEMI 患者进行分层,以便进行针对性的干预。